BridgeBio Pharma, Inc. · NASDAQ:BBIO
BlackRock, Inc.'s stake in BridgeBio Pharma, Inc. fell to 4.96% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc.'s stake in BridgeBio Pharma, Inc. fell to 4.96%, 9,733,762 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 4.96%
- Shares
- 9,733,762
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.96% | 9,733,762 |
Source
Related
- BridgeBio Pharma, Inc.
- BlackRock, Inc.
- BridgeBio Pharma, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026
- Form 4 · Kumar Neil · Nov 20, 2026
- Form 4 · Kumar Neil · Nov 18, 2026
- Form 4 · Apuli Maricel · Nov 18, 2026
- Form 4 · Trimarchi Thomas · Nov 18, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 12, 2026